Bovine leukemia virus p24 antibodies reflect blood proviral load

BMC Veterinary Research

Karina Trono¹  Mario Poli²  Norberto Fondevila¹  Marina Lomonaco¹  Mariela Gammella¹  Romina Politzki¹  Natalia Porta¹  Cecilia Martínez¹  Irene Alvarez¹  Hugo Carignano²  Gerónimo Gutiérrez¹ 

[1] Instituto de Virología. Centro de Investigaciones en Ciencias Veterinarias y Agronómicas, INTA, C.C. 1712, Castelar, Argentina;Instituto de Genética. Centro de Investigaciones en Ciencias Veterinarias y Agronómicas, INTA, C.C. 1712, Castelar, Argentina

关键词: p24 antibodies;    ROC curve;    Serological marker;    Control measures;    Proviral load;    BLV;   

Others  :  1119700
DOI  :  10.1186/1746-6148-8-187

 received in 2012-06-15, accepted in 2012-10-04,  发布年份 2012

【 摘 要 】

Background

Bovine leukemia virus (BLV) is worldwide distributed and highly endemic in Argentina. Among the strategies to prevent BLV dissemination, a control plan based on the selective segregation of animals according to their proviral load (PVL) is promising for our dairy productive system. The objective of this work was to study the relationship between the blood PVL and the antibody level, in order to identify whether the individual humoral response, i.e. the anti-p24 or anti-whole-BLV particle, could be used as a marker of the blood level of infection and thus help to recruit animals that may pose a lower risk of dissemination under natural conditions.

Results

The prevalence of p24 antibodies on the 15 farms studied was over 66%. The prevalence of p24 and whole-BLV antibodies and PVL quantification were analyzed in all the samples (n = 196) taken from herds T1 and 51. ROC analysis showed a higher AUC for p24 antibodies than whole-BLV antibodies (Z_reactivity: 3.55, P < 0.001; Z_titer: 2.88, P < 0.01), and as consequence a better performance to predict the proviral load status in herd 51. No significant differences were found between the performance of p24 and whole-BLV antibodies in herd T1. A significant positive correlation was observed between PVL values and p24 antibody reactivity in both farms (r _T1 = 0.7, P < 0.001, r ₅₁ = 0.71, P < 0.0001). The analysis was extended to the whole number of weak p24 antibody reactors (n = 311) of the other 13 farms. The mean of high PVL reactors within weak p24 reactors was 17.38% (SD = 8.92). In 5/15 farms, the number of weak p24 reactors with high PVL was lower than 10%.

Conclusions

We found that the humoral response reflected the level of in vivo infection, and may therefore have useful epidemiological applications. Whereas the quantitative evaluation of blood proviral load using real-time PCR is expensive and technically demanding, the measurement of antibodies in blood by ELISA is relatively straightforward and could therefore constitute a cost-effective tool in a BLV control intervention strategy, especially in highly infected herds such as Argentinean dairy ones.

【 授权许可】

   
2012 Gutierrez et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Trono KG, Pérez-Filgueira DM, Duffy S, Borca MV, Carrillo C: Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet Microbiol 2001, 83:235-248.
• [2]Rodríguez SM, Florins A, Gillet N, de Brogniez A, Sánchez-Alcaraz MT, Boxus M, Boulanger F, Gutiérrez G, Trono K, Alvarez I, Vagnoni L, Willems L: Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses 2011, 3:1210-1248.
• [3]Gutiérrez G, Alvarez I, Politzki R, Lomónaco M, Dus Santos MJ, Rondelli F, Fondevila N, Trono K: Natural progression of bovine leukemia virus infection in Argentinean dairy cattle. Vet Microbiol 2011, 151:255-263.
• [4]Juliarena MA, Gutiérrez SE, Ceriani C: Determination of proviral load in bovine leukemia virus-infected cattle with and without lymphocytosis. Am J Vet Res 2007, 68:1220-1225.
• [5]Mammerickx M, Portetelle D, de Clercq K, Burny A: Experimental transmission of enzootic bovine leukosis to cattle, sheep and goats: infectious doses of blood and incubation period of the disease. Leuk Res 1987, 11:353-358.
• [6]Gutiérrez G, Alvarez I, Fondevila N, Politzki R, Lomónaco M, Rodríguez S, Dus Santos MJ, Trono K: Detection of bovine leukemia virus specific antibodies using recombinant p24-ELISA. Vet Microbiol 2009, 137:224-234.
• [7]Lew AE, Bock RE, Molloy JB, Minchin CM, Robinson SJ, Steer P: Sensitive and specific detection of proviral bovine leukemia virus by 5’ Taq nuclease PCR using a 3’ minor groove binder fluorogenic probe. J Virol Methods 2004, 115:167-175.
• [8]Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:2002-2007.
• [9]Hopkins SG, DiGiacomo RF: Natural transmission of bovine leukemia virus in dairy and beef cattle. Vet Clin North Am Food Anim Pract 1997, 13:107-128.
• [10]Burny A, Cleuter Y, Kettmann R, Mammerickx M, Marbaix G, Portetelle D, Van den Broeke A, Willems L, Thomas R: Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv 1987, 6:139-159.
• [11]Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepère JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de Thé G, Moreau JP, Gessain A: Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 1999, 82:832-836.
• [12]Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, Urbain P, Vandermeers F, Debacq C, Sanchez-Alcaraz MT, Schwartz-Cornil I, Kerkhofs P, Jean G, Théwis A, Hay J, Mortreux F, Wattel E, Reichert M, Burny A, Kettmann R, Bangham C, Willems L: Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci 2007, 12:1520-1531.
• [13]Monti GE, Frankena K, De Jong MC: Transmission of bovine leukaemia virus within dairy herds by simulation modelling. Epidemiol Infect 2007, 135:722-732.
• [14]Burbelo PD, Meoli E, Leahy HP, Graham J, Yao K, Oh U, Janik JE, Mahieux R, Kashanchi F, Iadarola MJ, Jacobson S: Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2008, 5:96. BioMed Central Full Text
• [15]Hisada M, Maloney EM, Sawada T, Miley WJ, Palmer P, Hanchard B, Goedert JJ, Manns A: Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica. Clin Infect Dis 2002, 34:1551-1557.
• [16]Mosley AJ, Asquith B, Bangham CR: Cell-mediated immune response to human T-lymphotropic virus type I. Viral Immunol 2005, 18:293-305.